Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-7,790
Closed -$276K 169
2016
Q1
$276K Buy
7,790
+6
+0.1% +$209 0.67% 64
2015
Q4
$308K Buy
7,784
+1,862
+31% +$72.4K 0.94% 40
2015
Q3
$239K Buy
+5,922
New +$235K 0.7% 67
2015
Q2
Sell
-2,426
Closed -$79K 257
2015
Q1
$79K Buy
+2,426
New +$74.5K 0.18% 171
2014
Q4
Sell
-3,302
Closed -$80K 274
2014
Q3
$80K Buy
3,302
+2,902
+726% +$73.3K 0.11% 195
2014
Q2
$10K Sell
400
-471
-54% -$11K 0.03% 137
2014
Q1
$18K Sell
871
-2,683
-75% -$57.9K 0.03% 206
2013
Q4
$80K Buy
+3,554
New +$78.4K 0.21% 121
2013
Q3
Sell
-34,980
Closed -$698K 225
2013
Q2
$698K Buy
+34,980
New +$731K 1.3% 19

Other funds holding HOLX

IKOS CIF's HOLX Position: Q2 2016 in Review

IKOS CIF sold out of Hologic (HOLX) in Q2 2016, closing a stake of 7,790 shares — an estimated $276K sold.

IKOS CIF first reported a position in HOLX in Q2 2013 and held it in 9 quarters. The position peaked at $698K in Q2 2013. 459 funds tracked by Wall St. Rank hold HOLX as of Q2 2016.

  • IKOS CIF reported no remaining Hologic position as of Q2 2016 after selling out during the quarter.
  • IKOS CIF sold 7,790 Hologic shares in Q2 2016, an estimated $276K.
  • IKOS CIF first reported a position in Hologic in Q2 2013 and held it in 9 quarters.
  • IKOS CIF's Hologic position peaked at $698K in Q2 2013.
  • 459 funds tracked by Wall St. Rank held Hologic as of Q2 2016.

Based on IKOS CIF's 13F filing for Q2 2016, filed 12 Aug 2016.